To create a healthier future for patients with life-threatening diseases, Engitix Therapeutics is using its pioneering human extracellular matrix (ECM)-based discovery platform to develop a portfolio of programmes in fibrosis and solid tumors.

Biotechnology

Engitix Therapeutics

Giuseppe Mazza

Simran Sagoo

Chris Stevenson

Athiva Shankar

Thomas Gobbetti

Calum MacLeod

Amélie Fortin

Alan Holmes

Luca Frenguelli

Lisa Longato

Amy Lewis

The Science Team at Engitix Therapeutics leverages their expertise in drug discovery, tissue engineering, and translational biology to advance the company's portfolio of programs targeting fibrosis and solid tumors. This team utilizes the company's human extracellular matrix (ECM)-based discovery platform to develop innovative therapeutic solutions, bringing together a multidisciplinary group of scientists and advisors to drive research and development.

Science Team

Research and Development

Finance and Operations

Science Team

About

Team members

Other teams at Engitix Therapeutics

Research and Development

Finance and Operations